[1] Da SF, Vasconcelos A, de Carvalho FL, et al. Association between the rs1143634 polymorphism in interleukin-1B and chronic periodontitis: Results from a meta-analysis composed by 54 case/control studies [J]. Gene, 2018, 668:97-106. [2] Groeger SE, Meyle J. Epithelial barrier and oral bacterial infection[J]. Periodontol 2000, 2015, 69(1):46-67. [3] Wang SS, Tang YL, Pang X, et al. The maintenance of an oral epithelial barrier [J]. Life Sci, 2019, 227:129-136. [4] Fields JK, Gunther S, Sundberg EJ. Structural basis of IL-1 family cytokine signaling [J]. Front Immunol, 2019, 10:1412. [5] Stephenson J, Nutma E, van der Valk P, et al. Inflammation in CNS neurodegenerative diseases [J]. Immunology, 2018, 154(2):204-219. [6] Ayazi G, Pirayesh M, Yari K. Analysis of interleukin-1beta gene polymorphism and its association with generalized aggressive periodontitis disease [J]. DNA Cell Biol, 2013, 32(7):409-413. [7] Chen SC, Constantinides C, Kebschull M, et al. MicroRNAs regulate cytokine responses in gingival epithelial cells [J]. Infect Immun, 2016, 84(12):3282-3289. [8] How KY, Song KP, Chan KG. Porphyromonas gingivalis: An overview of periodontopathic pathogen below the gum Line [J]. Front Microbiol, 2016, 7:53. [9] Kato H, Taguchi Y, Tominaga K, et al. Porphyromonas gingivalis LPS inhibits osteoblastic differentiation and promotes pro-inflammatory cytokine production in human periodontal ligament stem cells [J]. Arch Oral Biol, 2014, 59(2):167-175. [10] Akkaoui J, Yamada C, Duarte C, et al. Contribution of porphyromonas gingivalis lipopolysaccharide to experimental periodontitis in relation to aging [J]. Geroscience, 2021, 43(1):367-376. [11] Petrasek J, Bala S, Csak T, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice [J]. J Clin Invest, 2012, 122(10):3476-3489. [12] Boraschi D, Tagliabue A. The interleukin-1 receptor family [J]. Semin Immunol, 2013, 25(6):394-407. [13] Li H, Shen S, Chen X, et al. miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway [J]. Cancer Cell Int, 2019, 19:205. [14] Chang YC, Sabourin CL, Lu SE, et al. Upregulation of gamma-2 laminin-332 in the mouse ear vesicant wound model [J]. J Biochem Mol Toxicol, 2009, 23(3):172-184. [15] Zboralski D, Warscheid B, Klein-Scory S, et al. Uncoupled responses of Smad4-deficient cancer cells to TNFalpha result in secretion of monomeric laminin-gamma2 [J]. Mol Cancer, 2010, 9(1):65. [16] Koivisto L, Bi J, Hakkinen L, et al. Integrin alphavbeta6: Structure, function and role in health and disease [J]. Int J Biochem Cell Biol, 2018, 99:186-196. [17] Niu J, Li Z. The roles of integrin alphavbeta6 in cancer [J]. Cancer Lett, 2017, 403:128-137. [18] Elkington PT, O'Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease [J]. Clin Exp Immunol, 2005, 142(1):12-20. [19] Zhang H, Liu L, Jiang C, et al. MMP-9 protects against LPS-induced inflammation in osteoblasts [J]. Innate Immun, 2020, 26(4):259-269. |